SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-21-000029
Filing Date
2021-05-04
Accepted
2021-05-04 08:04:22
Documents
16
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20210504.htm   iXBRL 8-K 34284
2 EX-99.1 pcrx-3312021x991.htm EX-99.1 184826
3 PACIRA BIOSCIENCES LOGO pacirabiosciencesa011.jpg GRAPHIC 27796
  Complete submission text file 0001396814-21-000029.txt   419129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20210504.xsd EX-101.SCH 2430
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20210504_cal.xml EX-101.CAL 718
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20210504_def.xml EX-101.DEF 1655
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20210504_lab.xml EX-101.LAB 24270
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20210504_pre.xml EX-101.PRE 12654
9 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20210504_htm.xml XML 11941
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 21886062
SIC: 2834 Pharmaceutical Preparations